Sign In
Buy LLY
$1,192.80
+22.94 (+1.96%)
At Close: Aug 06, 2026
Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook
07:00am, Thursday, 19'th Dec 2024
Eli Lilly's diverse product portfolio and promising pipeline, including Tirzepatide, Orforglipron, and Retatrutide, support a "buy" rating for long-term investors despite current valuation metrics. Ze
These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?
05:26am, Thursday, 19'th Dec 2024
It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow va
This Is Huge News for Eli Lilly Investors
04:44am, Thursday, 19'th Dec 2024
The hottest area among healthcare investors right now revolves around advancements being made in weight loss. Known as glucagon-like peptide-1 (GLP-1) receptor agonists, blockbuster drugs such as Ozem
Scouting America Receives $30 million Grant from Lilly Endowment to Build Character in the Nation's Young People
01:03pm, Wednesday, 18'th Dec 2024
IRVING, TX, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Scouting America, the nation's foremost youth program of character development and values-based leadership training, has been awarded a grant of $30 milli
Merck's weight-loss pill deal: what it means for Eli Lilly
12:02pm, Wednesday, 18'th Dec 2024
Merck & Co Inc (NYSE: MRK) is in focus this morning after announcing a $2.0 billion deal with Hansoh Pharma. The said agreement wins it rights to HS-10535 – an experimental weight-loss pill (oral)
This Feels Like the Post-Pandemic Rally. 3 Stocks to Buy If It Is
11:13am, Wednesday, 18'th Dec 2024
The incredible returns equity investors have seen in 2024, and over the past couple months for that matter, have been incredible.
Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug
06:15am, Wednesday, 18'th Dec 2024
When you think of a top weight loss drug, chances are that Ozempic is the name that first comes to mind. Although it is approved for diabetes (Wegovy is the equivalent version, which is approved for w
BEIJING and BRIDGEWATER, N.J. , Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (
Eli Lilly Is Putting Dividend Growth Stocks to Shame With Yet Another Huge Increase to Its Payout
05:11am, Wednesday, 18'th Dec 2024
Dividend investors often prioritize stocks that have long track records for raising their payouts. But that can be a mistake.
Eli Lilly's Alzheimer's treatment approved in China
08:50pm, Tuesday, 17'th Dec 2024
China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January, the company sa
Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease
08:00pm, Tuesday, 17'th Dec 2024
China is the fourth major market where Kisunla has received approval Kisunla was first approved in the United States in July 2024, approved in Japan in September 2024 and then in Great Britain
NVS vs. LLY: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 17'th Dec 2024
Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value investors?
4 Big Drug Stocks That May Continue to Outperform in 2025
11:06am, Tuesday, 17'th Dec 2024
Gilead, Eli Lilly, Vertex Pharmaceuticals and AbbVie have outperformed the industry this year and are likely to see continued momentum in 2025.
15 Billion Reasons to Love Eli Lilly Stock Right Now
09:45am, Tuesday, 17'th Dec 2024
Pharmaceutical giant Eli Lilly (LLY 0.47%) is having a moment right now. Over the last two years the company has made a splash in the weight loss space thanks to its one-two punch of blockbuster diabe
Eli Lilly: A Rare Buying Opportunity
06:20am, Tuesday, 17'th Dec 2024
Eli Lilly's robust product portfolio, strategic acquisitions, and innovation-led initiatives drive its strong growth, positioning it well in the weight-loss, immunology, and oncology markets. LLY's ke
